Track topics on Twitter Track topics that are important to you
AMERICAN FORK, Utah, Aug. 06, 2015 (GLOBE NEWSWIRE) -- Golden Phoenix Minerals, Inc. (OTC Bulletin Board:GPXM) (“Golden Phoenix” or the “Company”) announced today that Mr. Patrick Highsmith has been appointed to the Company’s Board of Directors, effective August 3, 2015.
Patrick Highsmith is a 25-year veteran of the mining industry, having worked in mine operations, exploration, and business development for Rio Tinto, BHP Billiton, and Newmont Mining. Mr. Highsmith is an experienced manager and director of public and private companies. Since 2008, Patrick has been involved in the founding, management, financing, and sale of junior mining companies, associated with more than $60 million in financings during this period. During his tenure as COO and CEO at Lithium One Inc., he led the discovery teams on the Sal de Vida and James Bay lithium projects. He negotiated Lithium One’s strategic joint venture with LG, KORES, and the Korean government on the Sal de Vida lithium and potash project in Argentina before co-engineering the 2012 sale of the company for over $100 million.
Patrick has evaluated and worked on more than 250 projects in 26 countries. He is a seasoned negotiator, having helped to forge all manner of joint ventures, investments, strategic partnerships, and acquisitions. During the last year, Patrick was involved in the start-up of the Golden Chest Mine and New Jersey Mill in northern Idaho. He is currently advising private investor groups on acquisitions of operating assets in the gold and base metals mining sectors.
Mr. Highsmith has a Bachelor of Science degree in Geological Engineering and a Master of Science in Economic Geology from the Colorado School of Mines. He also brings to Golden Phoenix an extensive network across the technical, business, and financial sectors of the mining industry.
Commenting on Mr. Highsmith’s appointment to the Board, Donald Gunn, President of Golden Phoenix stated, “We are extremely pleased with Patrick’s decision to join our Board of Directors. As we conclude the settlement of outstanding legal matters, we look forward to the valuable contribution of Patrick’s industry expertise and project management experience to guide us in our property exploration, development and related financing efforts.”
About the Company: Golden Phoenix Minerals, Inc. is a U.S. mining and exploration company with significant property holdings in the Silver Peak Mining District near Tonopah, Nevada. The Company seeks to maximize the value of its gold and silver assets through exploration, joint venture, or mineral royalties. More information on the Company can be found at www.goldenphoenix.us.
Forward-Looking Statements: Information contained herein regarding pending legal matters or strategy, optimism related to the business, expanding exploration, development activities and other such statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and are subject to the safe harbors created thereby. While the Company believes such statements are reasonable, they are based on current expectations, estimates and projections about the Company's business and are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description limited herein due to many factors including continued market prices for the Company’s mineral products, domestic and international business and economic conditions, and other risk factors listed in the Company's Securities and Exchange Commission (SEC) filings under “risk factors” and elsewhere. The Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
For More Information, Contact: Golden Phoenix Investor Relations Telephone (801) 418-9378 Email: email@example.comNEXT ARTICLE
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...